RxDoctor Payments Data

Bernardo Cortese, MD

Interventional Cardiology · Cleveland, OHNPI 1457180382

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Boston Scientific at 29.6% of the total.

$45,369in general payments, 2019–2025

Across 83 payments — averaging $546.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$13K
  • Angiodynamics, Inc.$10K
  • Shockwave Medical, Inc$9K
  • Abbott$8K
  • Gentuity, LLC$3K
  • Abiomed$608
  • plus $627 from 2 others
$54,228in research payments, 2019–2025

Across 5 payments — averaging $10,846 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • M.a. Med Alliance S.A.$27K
  • Medtronic$27K

What the payments were for

  • Consulting fees$24,72755%
  • Speaking & faculty fees$11,57526%
  • Travel & lodging$3,9259%
  • Food & beverage$5,14211%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific28$13,451
Angiodynamics, Inc.12$10,111
Shockwave Medical, Inc8$9,487
Abbott20$7,955
Gentuity, LLC2$3,129
Abiomed7$608
Medtronic5$326
BD1$302

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,369 in reported general payments places this provider in the 80th percentile of 256 interventional cardiology providers in Ohio.

See all interventional cardiology providers in Ohio

Medicare billing

Part B allowed, 2024
$24,461
Medicare patients
42
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →